Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.

Allen RJ, Guillen-Guio B, Oldham JM, Ma SF, Dressen A, Paynton ML, Kraven LM, Obeidat M, Li X, Ng M, Braybrooke R, Molina-Molina M, Hobbs BD, Putman RK, Sakornsakolpat P, Booth HL, Fahy WA, Hart SP, Hill MR, Hirani N, Hubbard RB, McAnulty RJ, Millar AB, Navaratnam V, Oballa E, Parfrey H, Saini G, Whyte MKB, Zhang Y, Kaminski N, Adegunsoye A, Strek ME, Neighbors M, Sheng XR, Gudmundsson G, Gudnason V, Hatabu H, Lederer DJ, Manichaikul A, Newell JD Jr, O'Connor GT, Ortega VE, Xu H, Fingerlin TE, Bossé Y, Hao K, Joubert P, Nickle DC, Sin DD, Timens W, Furniss D, Morris AP, Zondervan K, Hall IP, Sayers I, Tobin MD, Maher TM, Cho MH, Hunninghake GM, Schwartz DA, Yaspan BL, Molyneaux PL, Flores C, Noth I, Jenkins RG, Wain LV.

Am J Respir Crit Care Med. 2019 Nov 11. doi: 10.1164/rccm.201905-1017OC. [Epub ahead of print]

PMID:
31710517
2.

Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities.

Fischer A, Strek ME, Cottin V, Dellaripa PF, Bernstein EJ, Brown KK, Danoff SK, Distler O, Hirani N, Jones KD, Khanna D, Lee JS, Lynch DA, Maher TM, Millar AB, Raghu G, Silver RM, Steen VD, Volkmann ER, Mullan RH, O'Dwyer DN, Donnelly SC.

QJM. 2019 Feb 1;112(2):81-93. doi: 10.1093/qjmed/hcy272. No abstract available.

PMID:
30605544
3.

Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities.

Fischer A, Strek ME, Cottin V, Dellaripa PF, Bernstein EJ, Brown KK, Danoff SK, Distler O, Hirani N, Jones KD, Khanna D, Lee JS, Lynch DA, Maher TM, Millar AB, Raghu G, Silver RM, Steen VD, Volkmann ER, Mullan RH, O'Dwyer DN, Donnelly SC.

Arthritis Rheumatol. 2019 Feb;71(2):182-195. doi: 10.1002/art.40769. Epub 2019 Jan 3. No abstract available.

PMID:
30604506
4.

VEGF (Vascular Endothelial Growth Factor) and Fibrotic Lung Disease.

Barratt SL, Flower VA, Pauling JD, Millar AB.

Int J Mol Sci. 2018 Apr 24;19(5). pii: E1269. doi: 10.3390/ijms19051269. Review.

5.

Scaling up cancer care in the WHO Eastern Mediterranean Region.

Lyons G, Sankaranarayanan R, Millar AB, Slama S.

East Mediterr Health J. 2018 Apr 5;24(1):104-110. No abstract available.

6.

Effects of hypoxia and hyperoxia on the differential expression of VEGF-A isoforms and receptors in Idiopathic Pulmonary Fibrosis (IPF).

Barratt SL, Blythe T, Ourradi K, Jarrett C, Welsh GI, Bates DO, Millar AB.

Respir Res. 2018 Jan 15;19(1):9. doi: 10.1186/s12931-017-0711-x.

7.

Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study.

Allen RJ, Porte J, Braybrooke R, Flores C, Fingerlin TE, Oldham JM, Guillen-Guio B, Ma SF, Okamoto T, John AE, Obeidat M, Yang IV, Henry A, Hubbard RB, Navaratnam V, Saini G, Thompson N, Booth HL, Hart SP, Hill MR, Hirani N, Maher TM, McAnulty RJ, Millar AB, Molyneaux PL, Parfrey H, Rassl DM, Whyte MKB, Fahy WA, Marshall RP, Oballa E, Bossé Y, Nickle DC, Sin DD, Timens W, Shrine N, Sayers I, Hall IP, Noth I, Schwartz DA, Tobin MD, Wain LV, Jenkins RG.

Lancet Respir Med. 2017 Nov;5(11):869-880. doi: 10.1016/S2213-2600(17)30387-9. Epub 2017 Oct 20.

8.

Development of tools to facilitate palliative and supportive care referral for patients with idiopathic pulmonary fibrosis.

Sharp C, Lamb H, Jordan N, Edwards A, Gunary R, Meek P, Millar AB, Kendall C, Adamali H.

BMJ Support Palliat Care. 2018 Sep;8(3):340-346. doi: 10.1136/bmjspcare-2017-001330. Epub 2017 Jun 30.

PMID:
28667087
9.

Differential Expression of VEGF-Axxx Isoforms Is Critical for Development of Pulmonary Fibrosis.

Barratt SL, Blythe T, Jarrett C, Ourradi K, Shelley-Fraser G, Day MJ, Qiu Y, Harper S, Maher TM, Oltean S, Hames TJ, Scotton CJ, Welsh GI, Bates DO, Millar AB.

Am J Respir Crit Care Med. 2017 Aug 15;196(4):479-493. doi: 10.1164/rccm.201603-0568OC.

10.

VEGF isoforms have differential effects on permeability of human pulmonary microvascular endothelial cells.

Ourradi K, Blythe T, Jarrett C, Barratt SL, Welsh GI, Millar AB.

Respir Res. 2017 Jun 2;18(1):116. doi: 10.1186/s12931-017-0602-1.

11.

A comparison of published multidimensional indices to predict outcome in idiopathic pulmonary fibrosis.

Sharp C, Adamali HI, Millar AB.

ERJ Open Res. 2017 Mar 14;3(1). pii: 00096-2016. doi: 10.1183/23120541.00096-2016. eCollection 2017 Jan.

12.

The role of microRNA-155/liver X receptor pathway in experimental and idiopathic pulmonary fibrosis.

Kurowska-Stolarska M, Hasoo MK, Welsh DJ, Stewart L, McIntyre D, Morton BE, Johnstone S, Miller AM, Asquith DL, Millar NL, Millar AB, Feghali-Bostwick CA, Hirani N, Crick PJ, Wang Y, Griffiths WJ, McInnes IB, McSharry C.

J Allergy Clin Immunol. 2017 Jun;139(6):1946-1956. doi: 10.1016/j.jaci.2016.09.021. Epub 2016 Oct 14.

13.

Duration of benefit following completion of pulmonary rehabilitation in interstitial lung disease-an observational study.

Sharp C, McCabe M, Hussain MJ, Dodd JW, Lamb H, Adamali H, Millar AB, Smith D.

QJM. 2017 Jan;110(1):17-22. doi: 10.1093/qjmed/hcw105. Epub 2016 Jul 10.

PMID:
27402855
14.

Ambulatory and short-burst oxygen for interstitial lung disease.

Sharp C, Adamali H, Millar AB.

Cochrane Database Syst Rev. 2016 Jul 6;7:CD011716. doi: 10.1002/14651858.CD011716.pub2. Review.

15.

Rituximab in autoimmune connective tissue disease-associated interstitial lung disease.

Sharp C, McCabe M, Dodds N, Edey A, Mayers L, Adamali H, Millar AB, Gunawardena H.

Rheumatology (Oxford). 2016 Jul;55(7):1318-24. doi: 10.1093/rheumatology/kew195. Epub 2016 Apr 8.

PMID:
27060110
16.

Lung function in pulmonary hypertension.

Low AT, Medford AR, Millar AB, Tulloh RM.

Respir Med. 2015 Oct;109(10):1244-9. doi: 10.1016/j.rmed.2015.05.022. Epub 2015 May 27. Review.

17.

Advances in understanding of the pathogenesis of acute respiratory distress syndrome.

Sharp C, Millar AB, Medford AR.

Respiration. 2015;89(5):420-34. doi: 10.1159/000381102. Epub 2015 Apr 25. Review.

18.

The role of biologics in treatment of connective tissue disease-associated interstitial lung disease.

Sharp C, Dodds N, Mayers L, Millar AB, Gunawardena H, Adamali H.

QJM. 2015 Sep;108(9):683-8. doi: 10.1093/qjmed/hcv007. Epub 2015 Jan 21. Review.

PMID:
25614613
19.

Improving care for patients with idiopathic pulmonary fibrosis (IPF) in the UK: a round table discussion.

Thickett DR, Kendall C, Spencer LG, Screaton N, Wallace WA, Pinnock H, Bott J, Pigram L, Watson S, Millar AB.

Thorax. 2014 Dec;69(12):1136-40. doi: 10.1136/thoraxjnl-2014-206284. Epub 2014 Oct 21.

PMID:
25335486
20.

Vascular endothelial growth factor in acute lung injury and acute respiratory distress syndrome.

Barratt S, Medford AR, Millar AB.

Respiration. 2014;87(4):329-42. doi: 10.1159/000356034. Epub 2013 Dec 20. Review.

21.

The Toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis.

O'Dwyer DN, Armstrong ME, Trujillo G, Cooke G, Keane MP, Fallon PG, Simpson AJ, Millar AB, McGrath EE, Whyte MK, Hirani N, Hogaboam CM, Donnelly SC.

Am J Respir Crit Care Med. 2013 Dec 15;188(12):1442-50. doi: 10.1164/rccm.201304-0760OC.

PMID:
24070541
22.

Detection of VEGF-A(xxx)b isoforms in human tissues.

Bates DO, Mavrou A, Qiu Y, Carter JG, Hamdollah-Zadeh M, Barratt S, Gammons MV, Millar AB, Salmon AH, Oltean S, Harper SJ.

PLoS One. 2013 Jul 31;8(7):e68399. doi: 10.1371/journal.pone.0068399. Print 2013.

23.

VEGF and sVEGFR-1 in malignant pleural effusions: association with survival and pleurodesis outcomes.

Hooper CE, Elvers KT, Welsh GI, Millar AB, Maskell NA.

Lung Cancer. 2012 Aug;77(2):443-9. doi: 10.1016/j.lungcan.2012.03.006. Epub 2012 Apr 7.

PMID:
22487430
24.

Hot off the breath: triple therapy for idiopathic pulmonary fibrosis--hear the PANTHER roar.

McGrath EE, Millar AB.

Thorax. 2012 Feb;67(2):97-8. doi: 10.1136/thoraxjnl-2011-201398. Epub 2011 Dec 8. No abstract available.

PMID:
22156778
25.

The role of IREB2 and transforming growth factor beta-1 genetic variants in COPD: a replication case-control study.

Chappell SL, Daly L, Lotya J, Alsaegh A, Guetta-Baranes T, Roca J, Rabinovich R, Morgan K, Millar AB, Donnelly SC, Keatings V, MacNee W, Stolk J, Hiemstra PS, Miniati M, Monti S, O'Connor CM, Kalsheker N.

BMC Med Genet. 2011 Feb 14;12:24. doi: 10.1186/1471-2350-12-24.

26.

VEGF in the lung: a role for novel isoforms.

Varet J, Douglas SK, Gilmartin L, Medford AR, Bates DO, Harper SJ, Millar AB.

Am J Physiol Lung Cell Mol Physiol. 2010 Jun;298(6):L768-74. doi: 10.1152/ajplung.00353.2009. Epub 2010 Mar 12.

27.

Association of MMP-2 polymorphisms with severe and very severe COPD: a case control study of MMPs-1, 9 and 12 in a European population.

Haq I, Chappell S, Johnson SR, Lotya J, Daly L, Morgan K, Guetta-Baranes T, Roca J, Rabinovich R, Millar AB, Donnelly SC, Keatings V, MacNee W, Stolk J, Hiemstra PS, Miniati M, Monti S, O'Connor CM, Kalsheker N.

BMC Med Genet. 2010 Jan 15;11:7. doi: 10.1186/1471-2350-11-7.

28.

Sympathetic innervation of the spleen in male Brown Norway rats: a longitudinal aging study.

Perez SD, Silva D, Millar AB, Molinaro CA, Carter J, Bassett K, Lorton D, Garcia P, Tan L, Gross J, Lubahn C, Thyagarajan S, Bellinger DL.

Brain Res. 2009 Dec 11;1302:106-17. doi: 10.1016/j.brainres.2009.09.012. Epub 2009 Sep 11.

29.

Vascular Endothelial Growth Factor (VEGF) isoform expression and activity in human and murine lung injury.

Medford AR, Douglas SK, Godinho SI, Uppington KM, Armstrong L, Gillespie KM, van Zyl B, Tetley TD, Ibrahim NB, Millar AB.

Respir Res. 2009 Apr 9;10:27. doi: 10.1186/1465-9921-10-27.

30.

Relationship between vascular endothelial growth factor + 936 genotype and plasma/epithelial lining fluid vascular endothelial growth factor protein levels in patients with and at risk for ARDS.

Medford ARL, Godinho SIH, Keen LJ, Bidwell JL, Millar AB.

Chest. 2009 Aug;136(2):457-464. doi: 10.1378/chest.09-0383. Epub 2009 Apr 6.

PMID:
19349383
31.

Diagnosis of ventilator-associated pneumonia.

Medford AR, Husain SA, Turki HM, Millar AB.

J Crit Care. 2009 Sep;24(3):473.e1-6. doi: 10.1016/j.jcrc.2008.06.012. Epub 2008 Sep 11.

PMID:
19327300
32.

Vascular endothelial growth factor receptor and coreceptor expression in human acute respiratory distress syndrome.

Medford AR, Ibrahim NB, Millar AB.

J Crit Care. 2009 Jun;24(2):236-42. doi: 10.1016/j.jcrc.2008.04.003. Epub 2008 Jul 9.

33.

Tumour necrosis factor-alpha processing in interstitial lung disease: a potential role for exogenous proteinase-3.

Armstrong L, Godinho SI, Uppington KM, Whittington HA, Millar AB.

Clin Exp Immunol. 2009 May;156(2):336-43. doi: 10.1111/j.1365-2249.2009.03906.x. Epub 2009 Mar 9.

34.

Sympathetic nervous system and lymphocyte proliferation in the Fischer 344 rat spleen: a longitudinal study.

Bellinger DL, Silva D, Millar AB, Molinaro C, Ghamsary M, Carter J, Perez S, Lorton D, Lubahn C, Araujoa G, Thyagarajan S.

Neuroimmunomodulation. 2008;15(4-6):260-71. doi: 10.1159/000156469. Epub 2008 Nov 26.

PMID:
19047803
35.

Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society.

Bradley B, Branley HM, Egan JJ, Greaves MS, Hansell DM, Harrison NK, Hirani N, Hubbard R, Lake F, Millar AB, Wallace WA, Wells AU, Whyte MK, Wilsher ML; British Thoracic Society Interstitial Lung Disease Guideline Group, British Thoracic Society Standards of Care Committee; Thoracic Society of Australia; New Zealand Thoracic Society; Irish Thoracic Society.

Thorax. 2008 Sep;63 Suppl 5:v1-58. doi: 10.1136/thx.2008.101691. No abstract available. Erratum in: Thorax. 2008 Nov;63(11):1029. multiple author names added.

PMID:
18757459
36.

Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD.

Chappell S, Daly L, Morgan K, Guetta-Baranes T, Roca J, Rabinovich R, Lotya J, Millar AB, Donnelly SC, Keatings V, MacNee W, Stolk J, Hiemstra PS, Miniati M, Monti S, O'Connor CM, Kalsheker N.

Eur Respir J. 2008 Oct;32(4):931-7. doi: 10.1183/09031936.00065308. Epub 2008 Jul 9.

37.

IL-10: Another therapeutic target in idiopathic pulmonary fibrosis?

Millar AB.

Thorax. 2006 Oct;61(10):835-6. No abstract available.

39.

Contribution of TNF-alpha converting enzyme and proteinase-3 to TNF-alpha processing in human alveolar macrophages.

Armstrong L, Godinho SI, Uppington KM, Whittington HA, Millar AB.

Am J Respir Cell Mol Biol. 2006 Feb;34(2):219-25. Epub 2005 Oct 6.

PMID:
16210695
41.

Vascular endothelial growth factor gene polymorphism and acute respiratory distress syndrome.

Medford AR, Keen LJ, Bidwell JL, Millar AB.

Thorax. 2005 Mar;60(3):244-8.

42.

Differential expression of Toll-like receptor (TLR)-2 and TLR-4 on monocytes in human sepsis.

Armstrong L, Medford AR, Hunter KJ, Uppington KM, Millar AB.

Clin Exp Immunol. 2004 May;136(2):312-9.

43.

Expression of functional toll-like receptor-2 and -4 on alveolar epithelial cells.

Armstrong L, Medford AR, Uppington KM, Robertson J, Witherden IR, Tetley TD, Millar AB.

Am J Respir Cell Mol Biol. 2004 Aug;31(2):241-5. Epub 2004 Mar 25.

PMID:
15044215
44.

Interleukin-22: a potential immunomodulatory molecule in the lung.

Whittington HA, Armstrong L, Uppington KM, Millar AB.

Am J Respir Cell Mol Biol. 2004 Aug;31(2):220-6. Epub 2004 Mar 23.

PMID:
15039135
45.

Analysis of an IL-10 polymorphism in idiopathic pulmonary fibrosis.

Whittington HA, Freeburn RW, Godinho SI, Egan J, Haider Y, Millar AB.

Genes Immun. 2003 Jun;4(4):258-64.

PMID:
12761561
46.

A role for vascular endothelial growth factor in acute and resolving lung injury.

Thickett DR, Armstrong L, Millar AB.

Am J Respir Crit Care Med. 2002 Nov 15;166(10):1332-7.

PMID:
12421742
47.

What is the role of the insulin-like growth factor system in the pathophysiology of cancer cachexia, and how is it regulated?

Crown AL, Cottle K, Lightman SL, Falk S, Mohamed-Ali V, Armstrong L, Millar AB, Holly JM.

Clin Endocrinol (Oxf). 2002 Jun;56(6):723-33.

PMID:
12072041
48.

The role of small airways in lung disease.

Shaw RJ, Djukanovic R, Tashkin DP, Millar AB, du Bois RM, Orr PA.

Respir Med. 2002 Feb;96(2):67-80. Review.

49.

Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome.

Thickett DR, Armstrong L, Christie SJ, Millar AB.

Am J Respir Crit Care Med. 2001 Nov 1;164(9):1601-5.

PMID:
11719296
50.

The balance between collagen synthesis and degradation in diffuse lung disease.

Thickett DR, Poole AR, Millar AB.

Sarcoidosis Vasc Diffuse Lung Dis. 2001 Mar;18(1):27-33. Review.

PMID:
11354545

Supplemental Content

Loading ...
Support Center